Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Invitae Pyruvate Metabolism and Related Disorders Panel Invitae United States | 40 | 38 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
2-OH Glutaric Aciduria Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 5 | 4 |
|
PreventionGenetics, part of Exact Sciences United States | 39 | 41 |
|
Congenital Myasthenic Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 58 | 31 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics, part of Exact Sciences United States | 292 | 253 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 202 | 212 |
|
Hydroxyglutaric Aciduria Panel PreventionGenetics, part of Exact Sciences United States | 4 | 4 |
|
Invitae Organic Acidemias Panel Invitae United States | 108 | 97 |
|
Metabolic epilepsy panel. 41-gene NGS panel. Genologica Medica Spain | 53 | 41 |
|
Epileptic encephalopathy panel. 128-gene NGS panel. Genologica Medica Spain | 197 | 128 |
|
Organic acidemia / Aciduria and cobalamin deficiency panel. NGS panel of 53 genes. Genologica Medica Spain | 53 | 53 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Combined D-2- and L-2-hydroxyglutaric aciduria: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Mitochondrial genome sequencing Molecular Vision Laboratory United States | 526 | 339 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Fulgent Genetics United States | 11 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.